Delivery Order SPE2DU25D9439-SPE2DU26FEEFW
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $4,422.16 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a ceiling of $499.999 billion authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $9,659.15 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract program with a $499.9 million ceiling authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $1,737.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency program that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a $3,184.64 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a DLA-administered indefinite delivery contract program with a $499.9 billion ceiling across multiple regional prime vendor contractors, structured to provide firm...
- The Defense Logistics Agency issued a $1,179.38 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal military healthcare facilities. The PPV-G GEN V is a Defense Logistics Agency-administered indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $2,041.58 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to federal healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. The contract authorizes firm fixed-price delivery orders for branded and...
- The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a $4,173.45 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a $499.999 billion ceiling and completion date of December 31, 2036. The contract authorizes...
- The Defense Logistics Agency issued a $1,398.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the delivery of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to...